Myriad Genetics Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Myriad Genetics Inc with three other
pharmaceutical manufacturers in North America:
Phibro Animal Health Corp
sales of $764.28 million
of which 65%
was Animal Health),
Lannett Company, Inc.
of which 100%
was Generic Pharmaceutical), and
Prestige Brands Holdings, Incorporation
of which 82%
was North Ameriican OTC Healthcare).
Myriad Genetics Inc reported sales of $771.40 million
June of 2017.
increase of 2.3%
versus 2016, when the company's sales were $753.80 million.
Sales of Others saw an increase
2.5% in 2017, from
$48.10 million to $49.30 million.